IQVIA Holdings Inc.
IQV Healthcare Diagnostics & Research
IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024. In the quarter to June 2026, revenue grew 8.74%, EPS was flat, free cash flow grew 23.3% and total debt rose 3.29%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.
Follow IQV
IQVIA Holdings Inc. (IQV) Return on invested capital
IQVIA Holdings Inc.'s return on invested capital over the twelve months to 30 June 2026 was 6.80%, up 0.1 percentage points from fiscal 2025 (6.75%). Over the past ten years it has ranged from 2.38% (fiscal 2017) to 35.0% (fiscal 2015); the current reading is higher than 73% of that period. That is above the Diagnostics & Research industry median of 0.00% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 6.75% | (0.81) |
| FY2024 | 7.56% | 0.80 |
| FY2023 | 6.76% | 0.22 |
| FY2022 | 6.54% | 1.32 |
| FY2021 | 5.22% | 2.52 |
| FY2020 | 2.70% | (0.16) |
| FY2019 | 2.86% | 0.14 |
| FY2018 | 2.72% | 0.34 |
| FY2017 | 2.38% | (0.05) |
| FY2016 | 2.43% | (32.53) |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| IDXX IDEXX Laboratories, Inc. compare | 48.9% |
| MTD Mettler-Toledo International, Inc. compare | 35.4% |
| ILMN Illumina, Inc. compare | 17.5% |
| A Agilent Technologies, Inc. compare | 11.1% |
| DGX Quest Diagnostics Incorporated compare | 7.94% |
| IQV IQVIA Holdings Inc. | 6.80% |
| LH Labcorp Holdings Inc. compare | 6.50% |
| WAT Waters Corporation compare | 1.05% |
| NTRA Natera, Inc. compare | −22.3% |
| Diagnostics & Research industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on IQV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement